BioNTech SE To Discuss on Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations Call Transcript
Good afternoon, good morning. My name is Ryan Richardson. I'm the Chief Strategy Officer of BioNTech, and I'm pleased to welcome you to our first Innovation Series event.
I'm joined here today by my colleagues, Ugur Sahin, our Co-Founder and Chief Executive Officer; Ozlem Tureci, Co-Founder, Chief Medical Officer; and Sierk Poetting, our Chief Operating Officer.
Just a couple of housekeeping items before we get started. The slides that we'll be presenting today can be found in the Investors section of our website. I'd like to remind you that we will be making forward-looking statements. You should not place undue reliance on such statements as actual outcomes could differ from those currently anticipated. For a full description of the risks, both financial and operational. Please refer to our Form 20-F, our annual report, which were filed with the SEC.
We have a full agenda today over the next couple of hours. Very excited to dig deeper into our pipeline, our innovation engine and the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
